70
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Detection of the Der (21)t(12;21) Chromosome Forming the TEL-AML1 Fusion Gene in Childhood Acute Lymphoblastic Leukemia

, &
Pages 43-50 | Accepted 16 Dec 1996, Published online: 01 Jul 2009

References

  • Mitelman F. Catalog of Chromosome Aberrations in Cancer. Alan R. Liss, New York 1994
  • Raimondi S. C., Williams D. L., Callihan T., Peiper S., Rivera G. K., Murphy S. B. Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood 1986; 68: 69
  • Kobayashi H., Maseki N., Homma C., Sakurai M., Kaneko Y. Clinical significance of chromosomal abnormalities in childhood acute lymphoblastic leukemia in Japan. Leukemia 1994; 8: 1944
  • Romana S. P., LeConiat M., Berger R. t(12;21): A new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosom Cancer 1994; 9: 186
  • Golub T. R., Barker G. F., Lovett M., Gilliiand D. G. Fusion of PDGF receptor beta to a novel ets‐like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994; 77: 1
  • Kobayashi H., Montgomery K. T., Bohlander S. K., Adra A. N., Lim B. L., Kucherlapati R. S., Donis‐Keller H., Holt M. S., Le Beau M. M., Rowley J. D. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. Blood 1994; 84: 3473
  • Golub T. R., Baker F. G., Bohlander S. K., Hiebert S. W., Ward D. C., Bray‐Ward P., Morgan E., Raimondi S. C., Rowley J. D., Gilliland D. G. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Nat Acad Sci U.S.A. 1995; 92: 4917
  • Romana S. P., Mauchauffé M., LeConiat M., Chumakov I., LePaslier D., Berger R., Bernard O. A. The t(12;21) of acute lymphoblastic leukemia results in a TEL‐AML1 gene fusion. Blood 1995; 85: 3662–3670
  • Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene. AML1, Proc Nat Acad Sci U.S.A. 1991; 88: 10431
  • Nucifora G., Begy C. R., Kobayashi H., Roulston D., Claxton D., Pedersen‐Bjergaard J., Parganas E., Ihre J. N., Rowley J. D. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and three unrelated genes at 3q26 (3;21)(q26;q22) translocations. Proc Natl Acad Sci U.S.A. 1994; 91: 4004
  • Romana S. P., Poirel H., LeConiat M., Flexor M. ‐A., Mauchauffé M., Jonveaux P., Macintyre E. A., Berger R., Bernard O. A. High frequency of t(12;21) in childhood B lineage acute lymphoblastic Leukemia. Blood 1995; 86: 4263
  • Shurtleff S. A., Buijs A., Behm F. G., Rubnitz J. E., Raimondi S. C., Hancock M. L., Chan G. C.‐F., Pui C. ‐H., Grosveld G., Downing J. R. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985
  • Liang D. ‐C., Chou T. ‐B., Chen J. ‐S., Shurtleff S. A., Rubnitz J. E., Drowning J. R., Pui C. ‐H., Shih L. ‐Y. High incidence of TEL‐AML1 fusion resulting from a cryptic t(12;21) in childhood B‐lineage acute lymphoblastic leukemia in Taiwan. Leukemia 1996; 10: 991
  • Cayuela J. ‐M., Baruchel A., Orange C., Madani A., Auclerc M. F., Daniel M. ‐T., Schaison G., Sigaux F. TEL‐AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B‐cell precursor acute lymphoblastic leukemia. Blood 1996; 88: 302
  • Nakao M., Yokota S., Horiike S., Taniwaki M., Kashima K., Sonoda Y., Koizumi S., Takaue Y., Matsushita T., Fujimoto T., Misawa S. Detection and quantification of TEL‐AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia 1996; 10: 1463
  • Kobayashi H., Satake N., Maseki N., Sakashita A., Kaneko Y. The der(21)t(12;21) chromosome is always formed in a 12;21 translocation associated with childhood acute lymphoblastic leukaemia. Brit J Haematol 1996; 94: 105
  • Miyoshi H., Ohira M., Shimizu K., Mitani K., Hirai H., Imai T., Yokoyama K., Soeda E., Ohki M. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res 1995; 23: 2762
  • Shih L. ‐Y., Chou T. ‐B., Liang D. ‐C., Tzeng Y. ‐S., Rubnitz J. E., Downing J. R., Pui C. ‐H. Lack of TEL‐AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan. Leukemia 1996; 10: 1456
  • Raynaud S., Mauvieux L., Cayuela J. M., Bastard C., Bilhou‐Nabera C., Debuire B., Bories D., Boucheix C., Charrin C., Fière D., Gabert J. TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia. Leukemia 1996; 10: 1529
  • Raynaud S., Cavé H., Baens M., Bastard C., Cacheux V., Grosgeorge J., Guidal‐Giroux C., Guo C., Vilmer E., Marrynen P., Grandchamp B. The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 1996; 87: 2891
  • Sato Y., Suto Y., Pietenpol J., Golub T. R., Gilliland D. G., Davis E. M., Le Beau M. M., Roberts J. M., Vogelstein B., Rowley J. D., Bohlander S. K. TEL and KIP1 define the smallest region of deletions on 12pl3 in hemotopoietic malignancies. Blood 1995; 86: 1525
  • Stegmaier K., Pendse S., Barker G. F., Bray‐Ward P., Ward D. C., Montgomery K. T., Krauter K. S., Reynolds C., Sklar J., Donnelly M., Bohlander S. K., Rowley J. D., Sallan S. E., Gilliland D. G., Golub T. R. Frequent loss of heterozygosity at TEL gene locus in acute lymphoblastic leukemia of childhood. Blood 1995; 86: 38
  • Cavé H., Gérard B., Martin E., Guidal C., Devaux I., Weissenbach J., Elion J., Vilmer E., Grandchamp B. Loss of heterozygosity in the chromosomal region 12pl2–13 is very common in childhood acute lymphoblastic leukemia and permits the precise localization of a tumor‐suppressor gene distinct from P27KIPI. Blood 1995; 86: 3869
  • Takeuchi S., Bartram C. R., Miller C. W., Reiter A., Seriu T., Zimmermann M., Schrappe M., Mori N., Slater J., Miyoshi I., Koeffler H. P. Acute lymphoblastic leukemia of childhood: Identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1. Blood 1996; 87: 3368
  • Kim D. ‐H., Moldwin R. L., Vignon C., Bohlander S. K., Suto Y., Giordano L., Gupata R., Fears S., Nucifora G., Rowley J. D., Smith S. D. TEL‐AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines. Blood 1996; 88: 785
  • Romana S. P., Le Coniat M., Poirel H., Bernard O. A., Berger R. Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia 1996; 10: 167
  • Liu P., Tarle S. A., Hajra A., Claxton D. F., Marlton P., Freedman M., Siciliano M. J., Collins F. S. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science 1993; 261: 1041
  • Meyers S., Downing J. R., Hiebert S. W. Identification of AML‐1 and t(8;21) translocation protein (AML‐1/ETO) as sequence specific DNA binding proteins: the runt homology domain is required for DNA binding and protein‐protein interactions. Mol Cell Biol 1993; 13: 6336
  • Shoemaker S. G., Hromas R., Kaushansky K. Transcriptional regulation of interleukin 3 gene expression in T lymphocytes. Proc Natl Acad Sci USA 1990; 87: 9650
  • Takahashi A., Satake M., Yamaguchi‐Iwai Y., Bae S. C., Lu J., Maruyama M., Zhang Y. W., Oka H., Arai N., Arai K., Ito Y. Positive and negative regulation of granulocyte‐macrophage colony‐stimulating factor promoter activity by AML1‐related transcription factor, PEBP2. Blood 1995; 86: 607
  • Nuchprayoon I., Meyers S., Scott L. M., Suzow J., Hiebert S., Friedman A. D. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2/CBF proto‐oncoproteins, regulates the murine myeloperoxidase and neutrophil esterase genes in immature myeloid cells. Mol Cell Biol 1994; 14: 5558
  • Okuda T., van Deursen J., Hiebert S. W., Grosveld G., Downing J. R. AML1, the target of multiple chromosomal translocation in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996; 84: 321
  • Le Beau M. M. Detecting genetic changes in human tumor cells: Have scientists “Gone fishing?”. Blood 1993; 81: 1979
  • Jenkins R. B., Le Beau M. M., Kraker W. J., Borrell T. J., Stalboerger P. G., Davis E. M., Penland L., Fernald A., Espinosa R., III, Schaid D. J., Noel P., Dewald G. W. Fluorescence in situ hybridization. A sensitive method for trisomy 8 detection in bone marrow specimens. Blood 1992; 79: 3307
  • Dreyling M. H., Kobayashi H., Olopade O. I., Le Beau M. M., Rowley J. D., Bohlander S. K. Detection of 9p deletions in leukemia cell lines by interphase fluorescence in situ hybridization with YAC‐derived probes. Cancer Genet Cytogenet 1995; 83: 46
  • Anastasi J., Thangavelu M., Vardiman J. W., Hooberman A. L., Bian M. L., Larson R. A., Le Beau M. M. Interphase cytogenetic analysis detects minimal residual disease in a case of acute lymphoblastic leukemia and resolves the question of relapse after allogeneic bone marrow transplantation. Blood 1991; 77: 1087
  • Anastasi J., Vardiman J. W., Rudinsky R., Patel M., Nachman J., Rubin C. M., Le Beau M. M. Direct correlation of cytogenetic findings with cell morphology using in situ hybridization: An analysis of suspicious cells in bone marrow specimes of two patients completing therapy for acute lymphoblastic leukemia. Blood 1991; 77: 2456
  • Campara D., Pui C. ‐H. Detection of minimal disease in acute leukemia: Methodlolgic advances and clinical significance. Blood 1995; 85: 1416
  • Kobayashi H., Espinosa R., III, Thirman M. J., Davis E., Diaz M. O., Le Beau M. M., Rowley J. D. Variability of 11q23 rearrangements in hematopoietic cell lines identified with fluorescence in situ hybridization. Blood 1993; 81: 3027
  • Bohlander S. K., Espinosa R., III, Fernald A. A., Rowley J. D., Le Beau M. M., Diaz M. O. Sequence‐independent amplification and labeling of yeast artificial chromosomes for fluorescence in situ hybridization. Cytogenet Cell Genet 1994; 65: 108

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.